Eur J Clin Invest 28:1946, PMID: 9568464 Kurdi M, Sivakumaran V, Duh RJ, Aon MA, Paolocci N, Booz GW (2012) Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes
The SURMOUNT-5 trial demonstrated superior weight loss with tirzepatide compared to semaglutide at 72 weeks
These occur in a significant proportion of patients, particularly during dose escalation, but they do not constitute a direct mechanism for iron depletion
However, pairing Semaglutide with CoolSculpting is a game-changing combination that can provide you with the much-needed boost to achieve your body goals faster and maintain them long-term
References [1] Judicial Panel on Multidistrict Litigation, December 2024 Order [2] PMC Article on Ozempic-Related Vision Loss [3] Endocrine Journal Study on Semaglutide and DVT Risk [4] CNBC Report on Novo Nordisk FDA Request [5] FDA Declaratory Order on Tirzepatide Shortage [6] Columbia Psychiatry News Report on GLP-1 Ethical Concerns